DCC and neoplasm: This antibody could block Netrin-1/Unc5B interaction to inhibit Netrin-1 induced tumor cell growth but does not inhibit Netrin-1/DCC interaction, suggesting that DCC and Unc5B also could interact with different Netrin-1 motifs in the EGF2 domain.